Hematopoietic Cell and Renal Transplantation in Plasma Cell Dyscrasia Patients
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Hematopoietic Cell and Renal Transplantation in Plasma Cell Dyscrasia Patients
Authors
Keywords
-
Journal
CELL TRANSPLANTATION
Volume 25, Issue 6, Pages 995-1005
Publisher
SAGE Publications
Online
2016-02-04
DOI
10.3727/096368915x688560
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Multiple Myeloma, Version 1.2013
- (2017) Kenneth C. Anderson et al. Journal of the National Comprehensive Cancer Network
- Renal Involvement in Monoclonal Gammopathy
- (2015) Turki Al-Hussain et al. ADVANCES IN ANATOMIC PATHOLOGY
- New aspects on the pathogenesis of renal disorders related to monoclonal gammopathies
- (2015) Stergios Kapoulas et al. Nephrologie & Therapeutique
- Myeloma-related Kidney Disease
- (2013) Nelson Leung et al. ADVANCES IN CHRONIC KIDNEY DISEASE
- Stable renal engraftment in a patient following successful tandem autologous/reduced-intensity conditioning allogeneic transplantation for treatment of multiple myeloma with del(17p) that developed as a post-transplantation lymphoproliferative disease following renal transplantation
- (2013) Tomohiro Aoki et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Renal transplant in plasma cell dyscrasias with lenalidomide treatment after autologous stem cell transplantation
- (2013) Ana Sánchez Quintana et al. NEPHROLOGY
- Successful Treatment of Renal Failure Caused by Multiple Myeloma With HLA-Identical Living Kidney and Bone Marrow Transplantation: A Case Report
- (2013) L. Wagner et al. TRANSPLANTATION PROCEEDINGS
- How I treat amyloidosis: the importance of accurate diagnosis and amyloid typing
- (2012) N. Leung et al. BLOOD
- Renal allografts in plasma cell myeloma hematopoietic cell graft recipients: on the verge of an explosion?
- (2012) L Nayak et al. BONE MARROW TRANSPLANTATION
- Monoclonal Gammopathy of Undetermined Significance and Smoldering Multiple Myeloma: A Review of the Current Understanding of Epidemiology, Biology, Risk Stratification, and Management of Myeloma Precursor Disease
- (2012) A. Agarwal et al. CLINICAL CANCER RESEARCH
- Tandem Autologous/Reduced-Intensity Conditioning Allogeneic Stem-Cell Transplantation Versus Autologous Transplantation in Myeloma: Long-Term Follow-Up
- (2011) Bo Björkstrand et al. JOURNAL OF CLINICAL ONCOLOGY
- Long-term outcomes of patients with light chain amyloidosis (AL) after renal transplantation with or without stem cell transplantation
- (2011) S. M. S. Herrmann et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Renal Improvement in Myeloma with Bortezomib plus Plasma Exchange
- (2011) Brian L. Burnette et al. NEW ENGLAND JOURNAL OF MEDICINE
- Multiple Myeloma
- (2011) Antonio Palumbo et al. NEW ENGLAND JOURNAL OF MEDICINE
- Long-Term Follow-Up of Recipients of Combined Human Leukocyte Antigen-Matched Bone Marrow and Kidney Transplantation for Multiple Myeloma With End-Stage Renal Disease
- (2011) Thomas R. Spitzer et al. TRANSPLANTATION
- Monoclonal Gammopathy of Undetermined Significance and Smoldering Multiple Myeloma
- (2010) Robert A. Kyle et al. Current Hematologic Malignancy Reports
- Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study
- (2009) O. Landgren et al. BLOOD
- Solid organ transplantation in survivors of hematopoietic cell transplantation: a single institution case series and literature review
- (2009) Amer Beitinjaneh et al. CLINICAL TRANSPLANTATION
- Acute cellular rejection in a renal allograft immediately following leukocyte engraftment after auto-SCT
- (2008) N Leung et al. BONE MARROW TRANSPLANTATION
- High-dose melphalan and auto-SCT in patients with monoclonal Ig deposition disease
- (2008) H Hassoun et al. BONE MARROW TRANSPLANTATION
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started